
INTRISENSE is a next-generation AI-powered platform built to revolutionize the clinical supply chain industry. Designed specifically to address the cost efficiencies, complexity, inefficiencies, and regulatory challenges inherent in clinical trials, INTRISENSE empowers clinical research organizations (CROs), pharmaceutical companies, biotech companies, contract research organizations, and clinical supply chain providers to operate more efficiently, effectively, faster, smarter, compliant, and safer—at every step of the clinical trial study lifecycle.
Developed by a team of experts at Intrinseque Health, INTRISENSE offers a centralized digital infrastructure that replaces outdated systems and manual processes with predictive intelligence, real-time data, and end-to-end visibility.
Clinical supply chains operate within an environment of constant change.
Study timelines evolve. Patient enrollment changes. Regulatory requirements differ between markets. Supply conditions shift. Service requirements become more complex. Unexpected events can affect carefully developed plans.
INTRISENSE was developed to help clinical supply teams look beyond the immediate operational picture and consider what may happen next.
By combining artificial intelligence, machine learning, data analysis and scenario-based intelligence, INTRISENSE helps transform complex clinical supply information into structured insights that support planning, preparation and decision-making.
Anticipate. Prepare. Plan.
Our vision at INTRISENSE is to redefine the future of clinical trial supply management by becoming the leading AI-driven platform that powers a more connected, compliant, and efficient ecosystem. We envision a world where clinical trials are free from avoidable delays, manual errors, and fragmented data—where intelligent systems work seamlessly to support global research that reaches patients faster and safer. Through innovation, integration, and insight, we aspire to build a resilient infrastructure that aligns with global regulatory standards and evolves with the pace of science. INTRISENSE will be the trusted backbone of clinical supply operations, enabling stakeholders across the industry to focus less on logistics and more on advancing human health.
At INTRISENSE, our mission is to transform the clinical supply chain landscape through intelligent automation, predictive analytics, and real-time visibility. We are committed to eliminating manual bottlenecks, reducing operational risks, and enhancing regulatory compliance by digitizing and integrating every step of the clinical trial study lifecycle. Built specifically for the life sciences sector, our AI-powered platform empowers sponsors, CROs, and supply chain partners to manage complexity with confidence—from early-phase trials to global, multi-site studies. We aim to ensure patient safety, trial continuity, and operational excellence by delivering accurate forecasting, seamless coordination, and proactive risk mitigation through a centralized and scalable platform. INTRISENSE is not just a tool—it’s a strategic partner built to support the dynamic needs of modern clinical research.

Predicts supply needs with high accuracy using protocol-specific and historical trial data.

Models disruptions like shipment delays or vendor issues and recommends preventive strategies.

Tracks location, temperature, and condition of clinical supplies in real time.

Monitors global regulatory sources and alerts stakeholders instantly on recalls and safety issues.

Selects qualified vendors and issues system-generated POs to speed up sourcing.

Tracks site-level stock levels, usage, and automatically flags low inventory thresholds.

Automatically logs every supply chain activity and generates reports for inspections.

Detects overstock or shortages and reallocates inventory between trial sites dynamically.

Offers role-based dashboards and sends proactive alerts on critical events.
From Complex Information to Forward-Looking Intelligence
NTRISENSE uses artificial intelligence and machine-learning technologies to analyse relevant information and support structured exploration of clinical supply scenarios.
The platform can support activities across three interconnected areas:
Identify potential regulatory, operational and supply scenarios that may affect a clinical development program.
Explore unforeseen circumstances and potential disruptions so appropriate contingencies can be considered in advance.
Support the development of robust clinical supply and service strategies with built-in contingencies, efficiencies and alternative approaches.
These capabilities are designed to work together rather than as isolated functions.
Whether you’re launching a trial, scaling diagnostics, or making sense of your data — we’re here to help.